Ranbaxy at back foot: Punjab’s plant (4th in India) banned by FDA

Ranbaxy Laboratories which is one of the largest and reputed companies of India, exports its drugs throughout the world. U.S. is the main consumer of generic drugs made at Ranbaxy but due to one defect found in the drugs of Toansa plant in Punjab, Ranbaxy got a setback on their reputation. This is the fourth plant of India which was banned by U.S. Food …

Patent on ICE COLD-PCR to Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases. It deals with patient testing, biomarker identification, and genetic assays through clinical trials on patients. Transgenomic Company recently got a patent of ICE COLD-PCR technology from U.S. Patent and Trademark Office, …

China’s New trademark Law from May 1, 2014

China would enforce new trademark law on May 1, 2014 that would aim to streamline and modernize the process. Not only this, law also ensures minimization of counterfeiting and squatting by the perpetrators. The new law would bring changes in all the procedural aspects related to trademark like filing, examination, prosecution and enforcement of trademarks. …

Law Suit by Invitae against Myriad regarding BRCA1/2 & MUTYH gene patent infringement

A case had been filed on Myriad Genetics by the Invitae Corporation in U.S. district court. The case demands a formal announcement from Myriad Genetics and withdrawal of all the charges on Invitae, as in an earlier case filed by the Myriad Genetics marked Invitae as defendant in an infringement case. In the reply, Invitae Co. said that Myriad certain …

Efavirenz (HIV Drug) case: Bristol (BMS) won over Mylan Pharma

Bristol Meyers Squibb (BMS), manufacturers of Efavirenz (patented drug for HIV) won over the companies named Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd. that made generic version of Efavirenz that is Sustiva. The companies filed an application in court for the permission to manufacture and sell Sustiva before the patent granted for Efavirenz …

Dedicated IP Courts to Improve China’s IP Image Worldwide

A new court would be set up to take care of IP matters in China. In order to make IP application and protection more efficient the proposal was given as a part of policy reform plan that was outlined by China’s President Xi Jinpeng and communist party on November 15, 2013. The proposal was a part of 60-point plan under “The decision on Major issues …

Pharmaceutical Companies shift from Small Molecule Drugs to Biotech Drugs

Recently, the Tufts University’s Center for the Study of Drug Development (CSDD) released an interesting report revealing the dramatic shift of pharmaceutical companies from manufacturing small molecule drugs to a large number of biotechnology drugs. The report shows that in 2001, the biotech products worldwide accounted for only 7% of the revenue …

Patent Litigation Integrity Act (S. 1612) introduced by Senator Hatch

US Senator Orrin Hatch has introduced the Patent Litigation Integrity Act (S. 1612). The Act aims to address the growing threat of patent trolls who purchase existing broad patents and then threaten businesses of infringing them. Patent litigation Integrity Act of 2013 provides two reform measures. One, the legislation introduced the mandatory fee shifting …